top of page
Innovative Therapies for Eye Diseases
SELAGINE, Inc. develops novel antibody-based biologic eye drops for treatment of immunological or inflammatory ocular surface diseases such as Dry Eye Disease, Sjögren’s syndrome and ocular Graft-versus-Host Disease.
SELAGINE Inc, 2315 W Taylor St, Ste A, Chicago, IL 60612
bottom of page